课题基金 / 基金详情

Regulation Of GTP-binding Proteins

Regulation Of GTP-binding Proteins
GTP 结合蛋白的调节
批准号:
7321529
负责人:
MARTHA VAUGHAN
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

MARTHA VAUGHAN的其他基金

相似基金

相关文献

中文摘要
翻译
Brefeldin A抑制的鸟嘌呤核苷酸交换蛋白BIG1和BIG2是ADP-核糖链因子GTP酶的激活剂,对调节细胞内细胞器之间的囊泡运输至关重要。生化分析和免疫荧光显微镜显示,在血清饥饿的HepG2细胞中,BIG1存在于细胞核、膜和胞浆中。在加入8-BR-cAMP后20min内,BIG1在细胞核内聚集,这一作用可被蛋白激酶A(PKA)抑制剂H-89和PKI阻断,这表明BIG1依赖于PKA催化的磷酸化。CAMP不改变BIG2的定位,BIG2小干扰RNA也不影响cAMP诱导的BIG1的核聚集。突变体BIG1(S883A)中Ala取代了一个可能的PKA磷酸化位点Ser-883,但不会随着cAMP的增加而移动到细胞核,而Asp(S883D)则导致BIG1在没有或有cAMP暴露的情况下核积累,这与该位点负电荷的机制重要性一致。核定位信号的突变(712KP714)抑制了BIG1在细胞核中的积累,而PKA催化的S883的磷酸化虽然是必要的,但不足以促进核积累,如双重突变S883D/核定位信号所示。微管在cAMP诱导的BIG1易位中的作用可以从诺康唑对其的抑制中推断出来。因此,我们确定了BIG1分子结构的另外两个关键元件,以及微管在新的PKA对BIG1易位的影响中的潜在功能。 腺苷二磷酸核糖化因子(ARF)在囊泡运输中起关键作用。Brefeldin A抑制的鸟嘌呤核苷酸交换蛋白(BIG)1和BIG2通过加速GTP取代结合的GDP而激活ARF。这些近似的附加和不同的功能。200 kDa的蛋白质及其独立的细胞内运动现在都被识别出来了。在这里,我们描述了免疫荧光显微镜下BIG2在COS7细胞中的定位,而不是BIG1,其结构具有在转铁蛋白(Tfn)摄取和TFn受体(TfnR)循环过程中回收内小体的特征。在摄取TFN 60min后,BIG2和Rab11的细胞含量增加,而TfnR、BIG1、Rab4和Exo70的含量没有增加。在TFN摄取60min后,密度梯度组分中出现了BIG2,而不是BIG1,其中含有TfnR、Rab 11和Exo70。用BIG2小干扰RNA(SiRNA)处理细胞,但不处理BIG1或对照siRNA,在不影响BIG1、ARF或肌动蛋白含量的情况下,BIG2蛋白减少不到90%,而TfnR显著增加,其在核周循环内小体中的积聚也是如此。BIG1 siRNA对TFN的释放无明显影响,但BIG2 siRNA单独或联合BIG1 siRNA处理的细胞TFN释放明显减慢。我们认为BIG2在Tfn摄取和TfnR循环中起重要作用,可能是通过它与Exo70和胞外包囊复合体的相互作用。 GEP100(P100)是一种ADP核糖化因子(ARF)鸟嘌呤核苷酸交换(GEP),与ARF6部分共存于细胞外周。P100优先加速 鸟苷5[γ-硫代]三磷酸(GTP-GammaS)与ARF6结合,参与质膜附近的蛋白质运输,包括受体循环、细胞黏附和细胞迁移。在这里,我们报道了以P100为诱饵的酵母双杂交筛选人胎脑cDNA文库,发现α-连环蛋白与α-连环蛋白特异相互作用,α-连环蛋白被认为是黏附连接和肌动蛋白细胞骨架重塑的调节因子。免疫共沉淀证实了P100与α-catenin的相互作用,虽然难以在显微镜下观察共定位,但在存在P100的情况下,α-catenin在体外增强了ARF6与GTP-GammaS的结合。经小干扰RNA(SiRNA)处理后,HepG2细胞中P100的缺失导致E-钙粘蛋白含量是对照组的3倍,并阻断了肝细胞生长因子诱导的E-钙粘蛋白的重新分布,这与ARF6在这一过程中的已知作用是一致的。在高表达野生型P100的正常大鼠肾(NRK)细胞中,F-肌动蛋白显著减少,但其GEP失活突变体的F-肌动蛋白没有明显减少,这也与P100在ARF6的激活中具有重要作用的结论一致,P100在E-钙粘蛋白循环和肌动蛋白重塑中都起着重要作用。
英文摘要
Brefeldin A-inhibited guanine nucleotide-exchange proteins, BIG1 and BIG2, are activators of ADP-ribosylaiton factor GTPases that are essential for regulating vesicular traffic among intracellular organelles. Biochemical analyses and immunofluorescence microscopy demonstrated BIG1 in nuclei as well as membranes and cytosol of serum-starved HepG2 cells. Within 20 min after addition of 8-Br-cAMP, BIG1 accumulated in nuclei, and this effect was blocked by protein kinase A (PKA) inhibitors H-89 and PKI, suggesting a dependence on PKA-catalyzed phosphorylation. BIG2 localization was not altered by cAMP, nor did BIG2 small interfering RNA influence nuclear accumulation of BIG1 induced by cAMP. Mutant BIG1 (S883A) in which Ala replaced Ser-883, a putative PKA phosphorylation site, did not move to the nucleus with cAMP addition, whereas replacement with Asp (S883D) resulted in nuclear accumulation of BIG1 without or with cAMP exposure, consistent with the mechanistic importance of a negative charge at that site. Mutation (712KP714) of the nuclear localization signal inhibited BIG1 accumulation in nuclei, and PKA-catalyzed phosphorylation of S883, although necessary, was not sufficient for nuclear accumulation, as shown by the double mutation S883D/nuclear localization signal. A role for microtubules in cAMP-induced translocation of BIG1 is inferred from its inhibition by nocodazole. Thus, two more critical elements of BIG1 molecular structure were identified, as well as the potential function of microtubules in a novel PKA effect on BIG1 translocation. ADP-ribosylation factors (ARFs) are critical in vesicular trafficking. Brefeldin A-inhibited guanine nucleotide-exchange protein (BIG)1 and BIG2 activate ARFs by accelerating replacement of bound GDP with GTP. Additional and differing functions of these approx. 200-kDa proteins are now being recognized, as are their independent intracellular movements. Here, we describe the localization in COS7 cells by immunofluorescence microscopy of BIG2, but not BIG1, with structures that have characteristics of recycling endosomes during transferrin (Tfn) uptake and Tfn receptor (TfnR) recycling. Cell content of BIG2 and Rab11, but not TfnR, BIG1, Rab4, or Exo70, was increased after 60 min of Tfn uptake. BIG2, but not BIG1, appeared in density-gradient fractions containing TfnR, Rab 11, and Exo70 after 60 min of Tfn uptake. Treatment of cells with BIG2 small interfering RNA (siRNA), but not BIG1 or control siRNAs, decreased BIG2 protein less than 90% without affecting BIG1, ARF, or actin content, whereas TfnR was significantly increased as was its accumulation in perinuclear recycling endosomes. Tfn release appeared unaffected by BIG1 siRNA but was significantly slowed from cells treated with BIG2 siRNA alone or plus BIG1 siRNA. We suggest that BIG2 has an important role in Tfn uptake and TfnR recycling, perhaps through its demonstrated interaction with Exo70 and the exocyst complex. GEP100 (p100) was identified as an ADP-ribosylation factor (ARF) guanine nucleotide-exchange (GEP) that partially colocalized with ARF6 in the cell periphery. p100 preferentially accelerated guanosine 5[gamma-thio]triphosphate (GTPgammaS) binding by ARF6, which participates in protein trafficking near the plasma membrane, including receptor recycling, cell adhesion, and cell migration. Here we report that yeast two-hybrid screening of a human fetal brain cDNA library using p100 as bait revealed specific interaction with alpha-catenin, which is known as a regulator of adherens junctions and actin cytoskeleton remodeling. Interaction of p100 with alpha-catenin was confirmed by coimmunoprecipitation of the endogenous proteins from human HepG2 or CaSki cells, although colocalization was difficult to demonstrate microscopically, alpha-Catenin enhanced GTPgammaS binding by ARF6 in vitro in the presence of p100. Depletion of p100 by small interfering RNA (siRNA) treatment in HepG2 cells resulted in E-cadherin content 3-fold that in control cells and blocked hepatocyte growth factor-induced redistribution of E-cadherin, consistent with a known role of ARF6 in this process. F-actin was markedly decreased in normal rat kidney (NRK) cells overexpressing wild-type p100, but not its GEP-inactive mutants, also consistent with the conclusion that p100 has an important role in the activation of ARF6 for its functions in both E-cadherin recycling and actin remodeling.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GTP-BINDING PROTEIN STRUCTURE/FUNCTION STUDIES
Molecular And Biochemical Characterization Of GTP-bindin
Regulation Of GTP-binding Proteins
Molecular Characterization and Regulation of GTP-binding Proteins
国内基金
海外基金
PAICS 介导氮代谢重编程通过调控GTP 合成驱动小细胞肺癌RPL10A 异质性与复发耐药的机制研究
  • 批准号:
    JCZRLH202601619
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
细胞外整合素配体分布和细胞内Rho GTP 酶活性协同调控肿瘤细胞迁移的力学生 物学机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    胡训武
  • 依托单位:
单细胞和空间转录组揭示近端小管上皮细胞内TMPO通过Rho GTP酶通路促进BK多瘤病毒肾病进展的研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    15.0万元
  • 批准年份:
    2024
  • 负责人:
    黄刚
  • 依托单位:
水稻小GTP酶ARFA1调控稻瘟病抗性的分子机制
  • 批准号:
    32472565
  • 项目类别:
    面上项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2024
  • 负责人:
    朱孝波
  • 依托单位: